Leading scientists continue to remove roadblocks by developing methods for synthesizing psychedelic compounds for further research.
The Mental Organs Hypothesis reconsiders the relationship between 5-HT2 receptors and the qualitative effects of psychedelics.
This compound exhibits reduced cardiotoxicity, psychoplastogen characteristics, and potential therapeutic effects in animal models.
Novel chemical variants of ibogaine may offer therapeutic benefits without severe side effects.
The MEQ is a self-report measure that provides insight into a key aspect of the psychedelic experience.
This study is the first of its kind to suggest that psilocybin enhances emotional empathy but does not affect moral behavior.
Researchers at the forefront of psychedelic science put forth their arguments in this important debate.
Changes in brain functioning, new synthesis methods, and psychotherapy dominate this year’s most-cited psilocybin papers.
This study provides meaningful access to some lesser-known magic mushroom compounds and conducts biological testing on them for the first time.
Interestingly, changes in migraine frequency were not correlated with the intensity of the acute psychotropic effects.